Rituximab-induced interleukin-15 reduction associated with clinical improvement in rheumatoid arthritis

Rituximab therapy alters all aspects of B-cell participation in the disturbed immune response of rheumatoid arthritis patients. To determine the impact of B-cell depletion on other immune compartments, we analysed levels of soluble and surface interleukin-15 (IL-15) along with the frequency of IL-15...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Díaz-Torné, César, Ortiz de Juana, M Angels, Geli, Carme, Cantó, Elisabet, Laiz, Ana, Corominas, Héctor, Casademont, Jordi, de Llobet, Josep M, Juárez, Cándido, Díaz-López, César, Vidal, Sílvia
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Science Inc 2014
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4080951/
https://ncbi.nlm.nih.gov/pubmed/24219764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imm.12212
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak